Nohla Therapeutics Garners $43,500,000 Series A Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d56c1563-2cbe-4deb-8ab0-efe0adab9b75 - Date
12/1/2016 - Company Name
Nohla Therapeutics - Mailing Address
1616 Eastlake Ave E Seattle, WA 98102 USA - Company Description
Nohla Therapeutics’ Scientific Advisors provide diversified expertise across our external advisory network. - Website
http://www.nohlatherapeutics.com - Transaction Type
Venture Equity - Transaction Amount
$43,500,000 - Transaction Round
Series A - Proceeds Purposes
The proceeds from the financing will support the Company’s two lead programs (NLA-101 and NLA-102) generated by Nohla’s novel technology platform, which was spun-out of the Fred Hutchinson Cancer Research Center (The Hutch) in September 2015. - M&A Terms
- Venture Investor
ARCH Venture Partners - Venture Investor
5AM Ventures - Venture Investor
Undisclosed
